Digest Network Come funziona
Network
/
Società
Ph
Non verificato

PharmaCyte Biotech, Inc.

Di cosa scriviamo

AccessoriBiotecnologiaFarmaceuticaSaluteVetrine/Shopping

4 comunicati stampa

Guarda tutti i comunicati
25/11/2025
Oncologia
Salute
Sanità
Farmaceutica
Biotecnologia
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
Fonte
PharmaCyte Biotech, Inc.
Emittente
Business Wire
1.00
0
02/09/2025
Associazioni/Professionisti
Salute
Tecnica
Farmaceutica
Biotecnologia
Mercato azionario
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
Fonte
PharmaCyte Biotech, Inc.
Emittente
Business Wire
1.00
0
20/08/2025
Biotecnologia
Farmaceutica
Salute
Oncologia
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
Fonte
PharmaCyte Biotech, Inc.
Emittente
Business Wire
1.00
0
18/08/2025
Biotecnologia
Farmaceutica
Salute
Finanza
Mercato azionario
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
Fonte
PharmaCyte Biotech, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0